DK0531413T3 - Et antiviralt præparat indeholdende prostratin - Google Patents

Et antiviralt præparat indeholdende prostratin

Info

Publication number
DK0531413T3
DK0531413T3 DK91910575T DK91910575T DK0531413T3 DK 0531413 T3 DK0531413 T3 DK 0531413T3 DK 91910575 T DK91910575 T DK 91910575T DK 91910575 T DK91910575 T DK 91910575T DK 0531413 T3 DK0531413 T3 DK 0531413T3
Authority
DK
Denmark
Prior art keywords
antiviral
prostratin
present
composition
preparation containing
Prior art date
Application number
DK91910575T
Other languages
Danish (da)
English (en)
Inventor
Michael R Boyd
Paul A Cox
Gordon M Cragg
Peter M Blumberg
Nancy A Sharkey
Junichi Ishitoya
James B Mcmahon
John A Beutler
Owen S Weislow
John H Ii Cardellina
Kirk R Gustafson
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0531413T3 publication Critical patent/DK0531413T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK91910575T 1990-05-30 1991-05-24 Et antiviralt præparat indeholdende prostratin DK0531413T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53056290A 1990-05-30 1990-05-30
PCT/US1991/003619 WO1991018595A1 (en) 1990-05-30 1991-05-24 An antiviral composition

Publications (1)

Publication Number Publication Date
DK0531413T3 true DK0531413T3 (da) 1999-05-25

Family

ID=24114097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91910575T DK0531413T3 (da) 1990-05-30 1991-05-24 Et antiviralt præparat indeholdende prostratin

Country Status (10)

Country Link
US (1) US5599839A (de)
EP (1) EP0531413B1 (de)
JP (1) JPH0737380B2 (de)
AT (1) ATE170075T1 (de)
AU (1) AU639343B2 (de)
CA (1) CA2083945C (de)
DE (1) DE69130063T2 (de)
DK (1) DK0531413T3 (de)
ES (1) ES2120962T3 (de)
WO (1) WO1991018595A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022103B2 (en) 2005-07-13 2011-09-20 Salvia Sciences, Inc. Ester prodrugs of prostratin and related phorbol compounds
US10369222B2 (en) 2012-01-18 2019-08-06 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters for the treatment of stroke
PT2368555T (pt) * 2007-01-31 2016-07-25 Biosuccess Biotech Company Composições e métodos de utilização de ésteres de forbol
US9974764B2 (en) 2007-01-31 2018-05-22 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters in the treatment of neoplasms
US11696908B2 (en) 2007-01-31 2023-07-11 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters
US9533938B2 (en) 2007-01-31 2017-01-03 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters for the treatment of stroke
US11564901B2 (en) 2007-01-31 2023-01-31 Biosuccess Biotech Co., Ltd. Compositions and methods of use of phorbol esters
US9636317B2 (en) 2007-01-31 2017-05-02 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters
US8067632B2 (en) 2007-07-26 2011-11-29 The Board Of Trustees Of The Leland Stanford Junior University Process to produce prostratin and structural or functional analogs thereof
EP2276478A4 (de) * 2008-04-11 2012-03-07 Aids Res Alliance Verfahren zur verabreichung von prostratin und strukturellen analoga davon
US20100298171A1 (en) * 2009-05-22 2010-11-25 Affymetrix, Inc. Apparatus for polymer synthesis
WO2011014561A1 (en) * 2009-07-29 2011-02-03 He Johnny J Extracts of medicinal plant and uses thereof
US10099996B2 (en) 2012-01-18 2018-10-16 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbol esters in the treatment of neoplasms
US9550722B2 (en) 2012-01-18 2017-01-24 Biosuccess Biotech Co. Ltd. Compositions and methods of use of phorbal esters for the treatment of stroke
ITUB20153575A1 (it) * 2015-09-11 2017-03-11 Fca Italy Spa "Sospensione per una ruota sterzante di autoveicolo, con asse di sterzo semi-virtuale"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902716A (en) * 1984-12-18 1990-02-20 Harbor Branch Oceanographic Institutuion, Inc. Anti-viral chamigrene derivatives

Also Published As

Publication number Publication date
WO1991018595A1 (en) 1991-12-12
JPH0737380B2 (ja) 1995-04-26
JPH05506451A (ja) 1993-09-22
AU639343B2 (en) 1993-07-22
US5599839A (en) 1997-02-04
AU7909991A (en) 1991-12-31
ES2120962T3 (es) 1998-11-16
DE69130063T2 (de) 1999-02-25
EP0531413A4 (en) 1993-06-16
CA2083945C (en) 1995-02-07
DE69130063D1 (de) 1998-10-01
ATE170075T1 (de) 1998-09-15
EP0531413B1 (de) 1998-08-26
EP0531413A1 (de) 1993-03-17

Similar Documents

Publication Publication Date Title
DK0531413T3 (da) Et antiviralt præparat indeholdende prostratin
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
FI862011A0 (fi) Terapeutiska nukleosider.
DK441786D0 (da) Nucleosider, der kan anvendes terapeutisk
AU1256288A (en) Treatment of human viral infections by dsrna combined with viral inhibitors
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
ATE87214T1 (de) Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
IE40860B1 (en) Substituted benzamides
HU907654D0 (en) Process for the production of medical preparations with increased stabilization, and without tissue-harming effect
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
FR2361404A1 (fr) Nouvelles 7-boxyiminoacylcephalosporines, leurs procedes de preparation et leur application en therapeutique
MC1930A1 (fr) Produit antiviral
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
EP0459176A3 (en) Oligophosphates with antiviral activity
DE69210737T2 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.
ES2051788T3 (es) Un producto farmaceutico.
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)